Oncolytics Biotech
Stock Forecast, Prediction & Price Target

Oncolytics Biotech Financial Estimates

Oncolytics Biotech Revenue Estimates

Oncolytics Biotech EBITDA Estimates

Oncolytics Biotech Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027 12/31/2028
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $7.91M
Low: $7.91M
High: $7.91M
avg. 0%
Avg: $43.86M
Low: $43.86M
High: $43.86M
avg. 454.07%
Avg: $101.25M
Low: $101.25M
High: $101.25M
avg. 130.83%
Avg: $251.81M
Low: $251.81M
High: $251.81M
avg. 148.70%
Net Income
 
% change YoY
$-26.30M
 
N/A
$-24.83M
 
5.58%
$-27.75M
 
-11.74%
Avg: $-24.19M
Low: $-25.71M
High: $-22.68M
avg. 12.79%
Avg: $-1.77M
Low: $-1.77M
High: $-1.77M
avg. 92.64%
Avg: $18.39M
Low: $18.39M
High: $18.39M
avg. 1133.56%
Avg: $64.52M
Low: $64.52M
High: $64.52M
avg. 250.79%
EBITDA
 
% change YoY
$-25.66M
 
N/A
$-28.17M
 
-9.79%
$-33.71M
 
-19.63%
Avg: $0
Low: $0
High: $0
avg. 100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$0.49
 
N/A
-$0.43
 
12.24%
-$0.41
 
4.65%
Avg: -$0.36
Low: -$0.38
High: -$0.34
avg. 12.71%
Avg: -$0.03
Low: -$0.03
High: -$0.03
avg. 92.64%
Avg: $0.27
Low: $0.27
High: $0.27
avg. 1133.56%
Avg: $0.95
Low: $0.95
High: $0.95
avg. 250.79%
Operating Expenses
 
% change YoY
$26.23M
 
N/A
$26.92M
 
2.62%
$33.79M
 
25.50%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Oncolytics Biotech stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 372.45% in 2025-2028.

We have gathered data from 3 analysts. Their low estimate is -25.71M, average is -24.19M and high is -22.68M.

What is Oncolytics Biotech stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 183.40% in 2025-2028.

We have gathered data from 4 analysts. Their low revenue estimate is $7.91M, average is $7.91M and high is $7.91M.

What is Oncolytics Biotech stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 372.43% in 2025-2028.

We have gathered data from 3 analysts. Their low earnings per share estimate is -$0.38, average is -$0.36 and high is $-0.33.